Invasive Fungal Infections Surveillance Initiative

Status Completed

Clinical Trial Summary

The purpose of this study is to optimize the management of patients treated for invasive fungal infections by establishing a real-time, continuous clinical data base that will capture and monitor trends in the epidemiology, diagnosis, treatment and outcomes of invasive fungal infections; reflect routine clinical management of patients with invasive fungal infections in order to evaluate treatment and provide a rationale for future treatment paradigms; and allow physicians to assess adherence to institutional clinical practice guidelines, validate current standardized definitions for patients with invasive fungal infections and promote change where appropriate.

Clinical Trial Description

Gender, height, weight, ethnicity, antifungal treatment, fungal colonization, laboratory results, past medical history, invasive fungal infection diagnosis, medications, outcomes ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00177944
Study type	Observational
Source	University of Pittsburgh
Contact
Status	Completed
Phase	N/A
Start date	August 2005
Completion date	August 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03641131` - Ampholipad Real-World Data in Taiwan
Not yet recruiting	`NCT03292224` - Systemic Fungal Infections in ICU Patients	N/A
Completed	`NCT01371656` - Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation	Phase 3
Completed	`NCT00936117` - Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia	Phase 2
Completed	`NCT00740389` - TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.	Phase 1
Completed	`NCT03857399` - Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin	Phase 2
Not yet recruiting	`NCT04215458` - Microbiota in Skin and Mucosa of Patients With Inflammatory Skin Diseases	N/A
Completed	`NCT03667690` - Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis	Phase 3
Completed	`NCT02957929` - Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally	Phase 1
Completed	`NCT01419678` - Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients	N/A
Recruiting	`NCT00333645` - Prophylaxis With Caspofungin in High-Risk Liver Transplantation	Phase 2
Not yet recruiting	`NCT03650439` - Fungal Infections in Patients With Hematological Malignancies
Completed	`NCT01303549` - Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients	Phase 4
Completed	`NCT00811642` - Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551)	Phase 3
Withdrawn	`NCT00430469` - Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients	Phase 1/Phase 2
Terminated	`NCT00386997` - ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic Leukemia	Phase 4
Completed	`NCT00514358` - Fluconazole Pharmacokinetics in Infants	Phase 1
Completed	`NCT04166669` - A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001	Phase 1
Recruiting	`NCT05150327` - Multicenter Cohort Study of Invasive Fungal Filamentous Fungal Infections in Liver Transplant Patients
Completed	`NCT02387983` - Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117)	Phase 1